Clinical Trial Portfolios: A Critical Oversight in Human Research Ethics, Drug Regulation, and Policy
Regulators rely on clinical trials for drug approval and labeling decisions. Health systems and clinicians rely on the evidence from trials to determine treatment, and patients rely on it to decide which courses of care to undertake. Many of these stakeholders presume that the careful review of indi...
| Authors: | ; |
|---|---|
| Format: | Electronic Article |
| Language: | English |
| Check availability: | HBZ Gateway |
| Interlibrary Loan: | Interlibrary Loan for the Fachinformationsdienste (Specialized Information Services in Germany) |
| Published: |
2019
|
| In: |
The Hastings Center report
Year: 2019, Volume: 49, Issue: 4, Pages: 31-41 |
| Online Access: |
Volltext (lizenzpflichtig) Volltext (lizenzpflichtig) |
